Glipizide Tablet, Film Coated, Extended Release
NDC Package 70518-1063-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Glipizide tablets is glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-1063 and is authorized under FDA application ANDA204720.

Identification & Billing

NDC Package Code
70518-1063-2
Package Description
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
70518-1063
11-Digit Billing Format
70518106302
RxNorm Crosswalk
  • RxCUI: 314006 - glipiZIDE 5 MG 24HR Extended Release Oral Tablet
  • RxCUI: 314006 - 24 HR glipizide 5 MG Extended Release Oral Tablet
  • RxCUI: 314006 - glipizide ER 5 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 314006 - glipizide XL 5 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Glipizide
Non-Proprietary Name
Glipizide
Substance Name
Glipizide
Dosage Form
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
GLIPIZIDE 5 mg/1
Pharmacologic Class
Usage Information
Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA204720
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-13-2018
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70518-1063). Click a package code to view its specific billing and regulatory data.

70518-1063-0
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
70518-1063-1
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-1063-2 identifies a specific commercial package of 30 tablet, film coated, extended release in 1 blister pack of Glipizide, a human prescription drug labeled by Remedyrepack Inc.. This tablet, film coated, extended release is formulated for oral use and contains glipizide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on March 13, 2018. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518106302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-1063-2
11-Digit CMS (5-4-2)
70518-1063-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.